Atig, Marilou .

HRN: 24-77-66  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/29/2024
CEFUROXIME 500MG (TAB)
03/29/2024
04/05/2024
PO
500 Mg Tab
BID
NSVD; Thinly Meconium-stained Amniotic Fluid
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Skin & Soft TissueUnspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: